ADHERENCE TO CHOLINESTERASE INHIBITORS IN PATIENTS WITH ALZHEIMER'S DISEASE

被引:15
|
作者
Blais, Lucie [1 ]
Kettani, Fatima-Zohra [1 ]
Perreault, Sylvie [1 ]
Leroux, Jean-Christophe [1 ]
Forget, Amelie [1 ]
Kergoat, Marie-Jeanne [2 ]
机构
[1] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Inst Univ Geriatrie Montreal, Montreal, PQ H3C 3J7, Canada
关键词
RIVASTIGMINE; DONEPEZIL;
D O I
10.1111/j.1532-5415.2009.02075.x
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:366 / 368
页数:3
相关论文
共 50 条
  • [1] Adherence to Cholinesterase Inhibitors in Alzheimer's Disease: A Review
    Brady, Roseanna
    Weinman, John
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2013, 35 (5-6) : 351 - 363
  • [2] Adherence, persistence and continuation with cholinesterase inhibitors in Alzheimer's disease
    Le Couteur, David G.
    Robinson, Maxine
    Leverton, Ann
    Creasey, Helen
    Waite, Louise
    Atkins, Kerry
    McLachlan, Andrew J.
    AUSTRALASIAN JOURNAL ON AGEING, 2012, 31 (03) : 164 - 169
  • [3] Switching cholinesterase inhibitors in patients with Alzheimer's disease
    Emre, M
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, : 64 - 72
  • [4] Cholinesterase inhibitors for Alzheimer's disease
    Finucane, TE
    LANCET, 2002, 360 (9342): : 1332 - 1332
  • [5] Cholinesterase inhibitors for Alzheimer's disease
    Hitzeman, Nathan
    AMERICAN FAMILY PHYSICIAN, 2006, 74 (05) : 747 - 749
  • [6] Cholinesterase Inhibitors for Alzheimer’s Disease
    Jaime Grutzendler
    John C. Morris
    Drugs, 2001, 61 : 41 - 52
  • [7] Cholinesterase inhibitors for Alzheimer's disease
    Stahl, SM
    HOSPITAL PRACTICE, 1998, 33 (11): : 131 - 136
  • [8] Cholinesterase inhibitors for Alzheimer's disease
    Birks, J
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (01):
  • [9] Cholinesterase inhibitors and Alzheimer's disease
    Euba, Rafael
    PSYCHIATRIC BULLETIN, 2006, 30 (02): : 76 - 76
  • [10] Cholinesterase inhibitors for Alzheimer's disease
    Grutzendler, J
    Morris, JC
    DRUGS, 2001, 61 (01) : 41 - 52